MISTY CAIN: Open Payments
NPI 1013548403 · FARMINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 14 payments from 10 companies in 2025. Trend: 2023 $28 · 2024 $111 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $54 |
| UCB, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Sandoz Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Viatris Specialty LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Globus Medical, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: VRAYLAR, Bimzelx, HYRIMOZ, SPRAVATO, YUPELRI, KISUNLA, AIRSUPRA, REXULTI.
Industry payments across MO — which companies pay providers there.
